Loading... Please wait...

Call 408-734-3800 / Toll Free 877-272-7241

Menu

Scientific Program

     The 5th CPC Symposium on Peptide Therapeutics  

 OCTOBER 11-13 2017 HANGZHOU   

 

PEPTIDE SCIENCE NEWS
Overview

PROGRAM SECTIONS

1. Overview and perspectives of peptide therapeutics
2. Peptide-based drug discovery and new technologies
3. Manufacturing and analytical development for peptide therapeutics
4. Peptide-based therapeutics in clinical development
5. Regulatory and investment discussion panel
Program
Registration
Events
Travel-Hotel
Past Year
 Social Media 
PDF Flyer
 
Partial List of Confirmed Speakers

Duu-Gong Wu
Ph.D., Former Deputy Division Director, CDER, FDA, USA

Dana Ault-Riche
Ph.D., Co-Founder and CEO, Reflexion Pharmaceuticals, USA

David Lin
Ph.D., Senior consultant, Former Acting Deputy Division Director, CDER, FDA Biologics Consulting Group, USA

Christopher A. Rhodes
Ph.D., President and CEO, President of Boulder Peptide Symposium, Drug Delivery Experts, USA

Anthony Partridge
Ph.D., Principal Scientist, Merck, USA

Soumitra Ghosh
Ph.D., Co-founder and CSO, President of Peptide Therapeutic Foundation, Avexegen Therapeutics, USA

Richard Pittner
Ph.D., Co-Founder, OXT Therapeutics and BioShore Partners, USA

Ranjan Chakrabarti
Ph.D., Vice President and Global Head of Biologics Lab Operations, USP, USA